title: Delayed-onset and long-lasting severe neutropenia due to rituximab.
abstract: BACKGROUND
  Rituximab, a monoclonal antibody, is effective in CD20-positive B-cell lymphoma and is now widely used either as a single agent or in combination with chemotherapy. The antibody's toxicity is generally mild and transient. There are reports of protracted neutropenia in patients treated with rituximab.
  
  
  METHODS
  We report on a patient with Burkitt's lymphoma treated with the hyper-CVAD chemotherapy regimen combined with rituximab. Four weeks after the five months' treatment marked neutropenia and hypogammaglobulinaemia occurred and persisted for one year. Both laboratory findings were not associated with severe infections in our patient.
  
  
  CONCLUSIONS
  Delayed-onset neutropenia is a newly recognised toxicity of rituximab treatment which may last up to one year and be complicated by serious infections.
authors.affiliation: Department of Medical Oncology, St. Claraspital, Basel, Switzerland. silvia.hofer@claraspital.ch
authors.forename: Silvia
authors.initials: S
authors.lastname: Hofer
authors.forename: Romaine
authors.initials: R
authors.lastname: Viollier
authors.forename: Christian
authors.initials: C
authors.lastname: Ludwig
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002051:Burkitt Lymphoma / Q000188:drug therapy*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects*; D003907:Dexamethasone / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects*; D018023:HIV Seronegativity; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000209:etiology*; D000069283:Rituximab; D013997:Time Factors; D014750:Vincristine / Q000009:adverse effects*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide